Atopy patch testing - A diagnostic tool?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 8, 1999, Pages 784-791

  De Bruin Weller, Marjolein S ^a   Knol, E F ^a   Bruijnzeel Koomen, C A F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; POLITEF; STEROID; TANNIN DERIVATIVE; TAR; TRIAMCINOLONE ACETONIDE;

ATOPIC DERMATITIS; ATOPY; CLINICAL FEATURE; HUMAN; METHODOLOGY; PATCH TEST; PRIORITY JOURNAL; REVIEW; SKIN; TIME; TOPICAL DRUG ADMINISTRATION;

ALLERGENS; ANIMALS; DERMATITIS, ATOPIC; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MITES; PATCH TESTS; SKIN;

EID: 0032814607     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00097.x     Document Type: Review

References (59)

1. 1. Kapp A. Atopic dermatitis: the skin manifestation of atopy. Clin Exp Allergy 1995;25:210-219.
2. 2. Coleman R, Trembath RC, Harper JI. Chromosome 11q13 and atopy underlying aopic eczema. Lancet 1993;341:1121-1112.
3. 3. Morren M-A, Przybilla B, Banelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994;31:467-473.
4. 4. Platts-Mills TAE, Mitchell EB, Rowntree S, Chapman MD, Wilkens SR. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233-247.
5. 5. Burges GE, Lang PG. Atopic dermatitis exacerbated by inhalant allergens. Arch Dermatol 1987;123:1437-1438.
6. 6. De Groot AC, Young E. The role of contact allergy to aeroallergens in atopic dermatitis. Contact Dermatitis 1989;21:209-214.
7. 7. Colloff MJ. Exposure of house dust mite in homes of people with atopic dermatitis. Br J Dermatol 1992;127:322-327.
8. 8. Beck HI, Korsgaard J. Atopic dermatitis and house dust mites. Br J Dermatol 1989;120:245-251.
9. 9. Henderson AJ, Kennedy CT, Thompson SJ, Carswell F. Temporal association between Der p I exposure, immediate hypersensitivity and clinical severity of eczema. Allergy 1990;45:445-450.
10. 10. Roberts DL. House dust mite avoidance and atopic dermatitis. Br J Dermatol 1984;110:735-739.
11. 12. August P. House dust mite causes atopic dermatitis. Br J Dermatol 1984;111 Suppl 26:10-11.
12. 11. Kubota Y, Imayama S, Hori Y. Reduction of environmental mites improved atopic dermatitis patients with positive mite-patch tests. J Dermatol 1992;19:177-180.
13. 13. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653-657.
14. 14. Colloff MJ, Lever RS, McSharry C. A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect an clinical status and mite populations. Br J Dermatol 1989;121:199-208.
15. 15. Tan BB, Weald D, Strickland I, Friedmann PS. Double blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347:15-18.
16. 16. Tuft L. Importance of inhalant allergens in atopic dermatitis. J Invest Dermatol 1949;12:211-219.
17. 17. Storck H. Neurodermitis disseminata mit Verschlimmerung im Sommer, aufflammen nach Inhalation von Pollenallergen. Dermatologica 1960;121:150-151.
18. 18. Tupker RA, de Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996;97:1064-1070.
19. 19. Brinkman L, Aslander MM, Raaijmakers JA, Lammers J-W, Koenderman L, Bruijnzeel-Koomen CA. Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge. Clin Exp Allergy 1997;27:1043-1051.
20. 20. Barnetson RS, Macfarlane HA, Benton EC. House dust mite allergy and atopic eczema: a case report. Br J Dermatol 1987;116:857-860.
21. 21. Gondo A, Saeki N, Tokuda Y. Challenge reactions in atopic dermatitis after percutaneous entry of mite antigen. Br J Dermatol 1986;115:485-493.
22. 22. Norris PG, Schofield O, Camp RD. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol 1988;118:435-440.
23. 23. Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H. House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): the relationship between HDM antigen in the skin and HDM antigen-specific IgE antibody. J Dermatol Sci 1992;3:73-77.
24. 24. Tanaka Y, Anan S, Yoshida H. Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Dermatol Sci 1990;1:361-368.
25. 25. Riley G, Siebers R, Rains N, Crane J, Fitzharris P. Der p 1 on human skin: time to wash more than the sheets? [Abstract]. Allergy 1998;53 Suppl 43:58.
26. 26. Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TAE. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982;1:127-130.
27. 27. Langeland T, Braathen LB, Borch M. Studies of atopic patch tests. Acta Derm Venereol Suppl (Stockh) 1989;144:105-109.
28. 28. Clark RA, Adinoff AR. Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool. J Am Acad Dermatol 1989;21:863-869.
29. 29. Bruijnzeel-Knomen CA, van Wichen DF, Spry CJ, Venge P, Bruijnzeel PL. Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 1988;118:229-238.
30. 30. van Voorst Vader PC, Lier JG, Woest TE, Coenraads PJ, Nater JP. Patch tests with house dust mite antigens in atopic dermatitis patients: methodological problems. Acta Derm Venereol (Stockh) 1991;71:301-305.
31. 31. Seidenari S, Manzini HM, Danese P, Gianetti A. Positive patch tests to whole mite culture and purified mite extracts in patients with atopic dermatitis, asthma, and rhinitis. Ann Allergy 1992;69:201-206.
32. 32. Imayama S, Hashizume T, Miyahara H, et al. Combination of patch test and IgE for dust mite antigens differentiates 130 patients with atopic dermatitis into four groups. J Am Acad Dermatol 1992;27:531-538.
33. 33. Langeveld-Wildschut EG, van Marion AM, Thepen T, Mudde GC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Evaluation of variables influencing the outcome of the atopy patch test. J Allergy Clin Immunol 1995;96:66-73.
34. 34. Bruijnzeel PL, Kuijper PH, Kapp A, Warringa RA, Betz S, Bruijnzeel-Koomen CA. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis. Clin Exp Allergy 1993;23:97-109.
35. 35. Dreborg S. Skin tests used in type 1 allergy testing [Position paper]. Allergy 1989;44 Suppl 10:22-30.
36. 36. Darsow U, Vieluf D, Ring J. Atopy patch test with different vehicles and allergen concentrations: an approach to standardization. J Allergy Clin Immunol 1995;95:677-684.
37. 37. Reitamo S, Visa K, Kahonen K, Kayhko K, Stubb S, Salo OP. Euzematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens. Br J Dermatol 1986;114:303-309.
38. 38. Adinoff AD, Tellez P, Clark RA. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol 1988;81:736-742.
39. 39. Young E, Bruijnzeel-Koomen CA, Berrens L. Delayed type hypersensitivity in atopic dermatitis. Acta Derm Venereol 1985;114 (Suppl):77-81.
40. 40. Feldman RJ, Maibach HI. Regional variation in percutaneous absorption of 14-cortisol in man. J Invest Dermatol 1967;38:181-183.
41. 41. Rothman S. Physiology and biochemistry of the skin Chicago: University of Chicago Press, 1954:120-152.
42. 42. Nilsson G, Brodin E. Tissue distribution of substance P-like immunoreactivity in dog, cat, rat and mouse. In: von Euler US, Pernow B, editors. Substance P. New York: Raven Press, 1954:49-54.
43. 43. Dubuis GR, Bruijnzeel-Koomen CA, Bruijnzeel PL. IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol 1994;102:843-846.
44. 44. Langeveld-Wildschut EG, Thepen T, Bihari IC, et al. Evaluation of the atopy patch test and the cutaneous late phase reaction, as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol 1996;98:1019-1027.
45. 45. Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996;97:828-837.
46. 46. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184-193.
47. 47. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992;89:801-810.
48. 48. van der Heyden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4 producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
49. 49. de Vries IJ, Langeveld-Wildschut EG, van Reijsen FC, et al. Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 1998;3:461-468.
50. 50. Mudde GC, van Reysen FC, Boland GJ, De Gast GC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335-341.
51. 51. Bruijnzeel-Koomen CA, van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PL. The presence of IgE molecules on epidermal Langerhans' cells in patients with atopic dermatitis. Arch Dermatol Res 1986;278:199-205.
52. 52. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973;52:38.
53. 53. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare reaction. Its dependence on IgE antibodies. J Clin Invest 1976;58:408-420.
54. 54. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-4164.
55. 55. Charlasworth EN. The skin as a model to study the pathogenesis of IgE-mediated acute and late-phase responses. J Allergy Clin Immunol 1994;94:1240-1250.
56. 56. Darsow U, Vieluf D, Ring J. The atopy patch test: an increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br J Dermatol 1996;135:182-186.
57. 57. Langeveld-Wildschut EG, Bruijnzeel PL, Mudde GC, et al. Clinical and immunological variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol (submitted).
58. 58. Wistokat-Wülfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T. Atopy patch test reactions are associated with T-lymphocyte mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999;29:513-521.
59. 59. Langeveld-Wildschut EG, Riedl H, Thepen T, Bihari IC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Modulation of the atopy patch test reaction by topical corticosteroids and tar. J Allergy Clin Immunol 1999 (in press).